GALXC

Welcome to the Brand page for “GALXC”, which is offered here for Custom manufacture of oligonucleotides;biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; biological compound in the form of a molecular complex that acts as a platform for the delivery of rna-based drugs to biological cells; and drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies;research and development of anti-cancer drugs and anti-cancer preparations; research and development of pharmaceutical products;.

Its status is currently believed to be active. Its class is unavailable. “GALXC” is believed to be currently owned by “Dicerna Pharmaceuticals, Inc.”